DE10331171A1 - Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung - Google Patents
Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung Download PDFInfo
- Publication number
- DE10331171A1 DE10331171A1 DE10331171A DE10331171A DE10331171A1 DE 10331171 A1 DE10331171 A1 DE 10331171A1 DE 10331171 A DE10331171 A DE 10331171A DE 10331171 A DE10331171 A DE 10331171A DE 10331171 A1 DE10331171 A1 DE 10331171A1
- Authority
- DE
- Germany
- Prior art keywords
- collagenase
- neutral protease
- tissue
- protease
- neutral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000035092 Neutral proteases Human genes 0.000 title claims abstract description 105
- 108091005507 Neutral proteases Proteins 0.000 title claims abstract description 105
- 108090000145 Bacillolysin Proteins 0.000 title claims abstract description 104
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 108091005804 Peptidases Proteins 0.000 title claims description 11
- 239000004365 Protease Substances 0.000 title claims description 10
- 230000007935 neutral effect Effects 0.000 title description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- 108060005980 Collagenase Proteins 0.000 claims abstract description 82
- 102000029816 Collagenase Human genes 0.000 claims abstract description 82
- 229960002424 collagenase Drugs 0.000 claims abstract description 65
- 241000193159 Hathewaya histolytica Species 0.000 claims abstract description 12
- 238000002955 isolation Methods 0.000 claims description 43
- 238000003860 storage Methods 0.000 claims description 23
- 238000010494 dissociation reaction Methods 0.000 claims description 19
- 230000005593 dissociations Effects 0.000 claims description 19
- 102000035195 Peptidases Human genes 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 241000894007 species Species 0.000 claims description 9
- 230000035899 viability Effects 0.000 claims description 9
- 230000000977 initiatory effect Effects 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 4
- 229940079919 digestives enzyme preparation Drugs 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 20
- 210000004027 cell Anatomy 0.000 description 34
- 210000004153 islets of langerhan Anatomy 0.000 description 30
- 210000000496 pancreas Anatomy 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 28
- 102000004190 Enzymes Human genes 0.000 description 25
- 108090000790 Enzymes Proteins 0.000 description 25
- 229940088598 enzyme Drugs 0.000 description 25
- 210000000056 organ Anatomy 0.000 description 13
- 108010052014 Liberase Proteins 0.000 description 12
- 230000007774 longterm Effects 0.000 description 12
- 241000282414 Homo sapiens Species 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- 230000029087 digestion Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 241000282898 Sus scrofa Species 0.000 description 6
- 230000006978 adaptation Effects 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 210000004923 pancreatic tissue Anatomy 0.000 description 6
- 235000019419 proteases Nutrition 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000000366 juvenile effect Effects 0.000 description 4
- 230000002438 mitochondrial effect Effects 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- -1 tetrazole compound Chemical class 0.000 description 4
- 101710105199 Collagenolytic protease Proteins 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000003366 colagenolytic effect Effects 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 229920001917 Ficoll Polymers 0.000 description 2
- 101000920185 Hathewaya histolytica Collagenase ColG Proteins 0.000 description 2
- 101000920186 Hathewaya histolytica Collagenase ColH Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 108700042768 University of Wisconsin-lactobionate solution Proteins 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 108090001092 clostripain Proteins 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 238000011552 rat model Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- ZEYOIOAKZLALAP-UHFFFAOYSA-M sodium amidotrizoate Chemical compound [Na+].CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I ZEYOIOAKZLALAP-UHFFFAOYSA-M 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 229940082150 encore Drugs 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011694 lewis rat Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013042 tunel staining Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Materials For Medical Uses (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10331171A DE10331171A1 (de) | 2003-07-09 | 2003-07-09 | Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung |
| EP04012321A EP1496112B1 (de) | 2003-07-09 | 2004-05-25 | Verfahren zur Isolierung von Inselzellen aus Pankreasgewebe |
| AT04012321T ATE471979T1 (de) | 2003-07-09 | 2004-05-25 | Verfahren zur isolierung von inselzellen aus pankreasgewebe |
| DE502004011298T DE502004011298D1 (de) | 2003-07-09 | 2004-05-25 | Verfahren zur Isolierung von Inselzellen aus Pankreasgewebe |
| US10/869,313 US8440445B2 (en) | 2003-07-09 | 2004-06-16 | Neutral protease (NP) and product by using neutral protease for tissue dissociation as well as method for the production thereof |
| CNA2004101005333A CN1626653A (zh) | 2003-07-09 | 2004-06-17 | 用于分离组织的中性蛋白酶（np）和使用中性蛋白酶的制品及其制备方法 |
| JP2004181373A JP2005046136A (ja) | 2003-07-09 | 2004-06-18 | 中性プロテアーゼおよび中性プロテアーゼを使った組織解離用生成物ならびにその製造方法 |
| CA2469137A CA2469137C (en) | 2003-07-09 | 2004-06-22 | Neutral protease (np) and product by using neutral protease for tissue dissociation as well as method for the production thereof |
| BRPI0402615-2A BRPI0402615B1 (pt) | 2003-07-09 | 2004-07-08 | Method for insulation of langerhans ilhotes from pancreatic tissue, and use of a purified neutral protease (np) |
| JP2010005801A JP2010081941A (ja) | 2003-07-09 | 2010-01-14 | 中性プロテアーゼおよび中性プロテアーゼを使った組織解離用生成物ならびにその製造方法 |
| JP2011102735A JP2011147458A (ja) | 2003-07-09 | 2011-05-02 | 中性プロテアーゼおよび中性プロテアーゼを使った組織解離用生成物ならびにその製造方法 |
| US13/862,773 US8765471B2 (en) | 2003-07-09 | 2013-04-15 | Neutral protease (NP) and product by using neutral protease for tissue dissociation as well as method for the production thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10331171A DE10331171A1 (de) | 2003-07-09 | 2003-07-09 | Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE10331171A1 true DE10331171A1 (de) | 2005-01-27 |
Family
ID=33441697
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10331171A Withdrawn DE10331171A1 (de) | 2003-07-09 | 2003-07-09 | Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung |
| DE502004011298T Expired - Lifetime DE502004011298D1 (de) | 2003-07-09 | 2004-05-25 | Verfahren zur Isolierung von Inselzellen aus Pankreasgewebe |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE502004011298T Expired - Lifetime DE502004011298D1 (de) | 2003-07-09 | 2004-05-25 | Verfahren zur Isolierung von Inselzellen aus Pankreasgewebe |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8440445B2 (https=) |
| EP (1) | EP1496112B1 (https=) |
| JP (3) | JP2005046136A (https=) |
| CN (1) | CN1626653A (https=) |
| AT (1) | ATE471979T1 (https=) |
| BR (1) | BRPI0402615B1 (https=) |
| CA (1) | CA2469137C (https=) |
| DE (2) | DE10331171A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010105820A1 (en) * | 2009-03-19 | 2010-09-23 | Roche Diagnostics Gmbh | Improved blends containing proteases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4408940A1 (de) | 1994-03-16 | 1995-10-05 | Boehringer Mannheim Gmbh | Rekombinante Collagenase Typ II aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden |
| CA2189646C (en) * | 1994-06-24 | 1999-05-25 | Francis E. Dwulet | A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum |
| DE4445891A1 (de) * | 1994-12-22 | 1996-06-27 | Boehringer Mannheim Gmbh | Rekombinante Proteinase aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden |
| US5989888A (en) | 1996-01-24 | 1999-11-23 | Roche Diagnostics Corporation | Purified mixture of collagenase I, collagenase II and two other proteases |
| ATE272109T1 (de) * | 1996-11-19 | 2004-08-15 | Roche Diagnostics Gmbh | Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden |
| US5830741A (en) * | 1996-12-06 | 1998-11-03 | Boehringer Mannheim Corporation | Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease |
| ATE302844T1 (de) | 2001-07-02 | 2005-09-15 | Nordmark Arzneimittel Gmbh & C | Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms |
-
2003
- 2003-07-09 DE DE10331171A patent/DE10331171A1/de not_active Withdrawn
-
2004
- 2004-05-25 EP EP04012321A patent/EP1496112B1/de not_active Expired - Lifetime
- 2004-05-25 AT AT04012321T patent/ATE471979T1/de active
- 2004-05-25 DE DE502004011298T patent/DE502004011298D1/de not_active Expired - Lifetime
- 2004-06-16 US US10/869,313 patent/US8440445B2/en not_active Expired - Fee Related
- 2004-06-17 CN CNA2004101005333A patent/CN1626653A/zh active Pending
- 2004-06-18 JP JP2004181373A patent/JP2005046136A/ja active Pending
- 2004-06-22 CA CA2469137A patent/CA2469137C/en not_active Expired - Fee Related
- 2004-07-08 BR BRPI0402615-2A patent/BRPI0402615B1/pt not_active IP Right Cessation
-
2010
- 2010-01-14 JP JP2010005801A patent/JP2010081941A/ja active Pending
-
2011
- 2011-05-02 JP JP2011102735A patent/JP2011147458A/ja not_active Withdrawn
-
2013
- 2013-04-15 US US13/862,773 patent/US8765471B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20050142632A1 (en) | 2005-06-30 |
| ATE471979T1 (de) | 2010-07-15 |
| EP1496112A3 (de) | 2005-10-12 |
| JP2005046136A (ja) | 2005-02-24 |
| US8765471B2 (en) | 2014-07-01 |
| EP1496112A2 (de) | 2005-01-12 |
| BRPI0402615A (pt) | 2005-06-28 |
| CA2469137C (en) | 2015-11-24 |
| CA2469137A1 (en) | 2005-01-09 |
| US20130230922A1 (en) | 2013-09-05 |
| BRPI0402615B1 (pt) | 2017-07-04 |
| JP2010081941A (ja) | 2010-04-15 |
| US8440445B2 (en) | 2013-05-14 |
| JP2011147458A (ja) | 2011-08-04 |
| CN1626653A (zh) | 2005-06-15 |
| DE502004011298D1 (de) | 2010-08-05 |
| EP1496112B1 (de) | 2010-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69525151T2 (de) | Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat | |
| DE3856121T2 (de) | Amyloid-Peptide | |
| Gonet et al. | Obesity and diabetes mellitus with striking congenital hyperplasia of the islets of langerhans in spiny mice (Acomys Cahirinus) I. Histological findings and preliminary metabolic observations | |
| DE69535328T2 (de) | In-vitro wachstum von langerhans'schen inseln und ihre verwendungen | |
| DE10134667A1 (de) | Verfahren zur Herstellung isolierter Zellkulturen, Kulturmedium zur Kultivierung von Zellkulturen und Zellkultur | |
| DD145927A5 (de) | Verfahren zur herstellung eines dn -transfer-vektors | |
| DE69531712T2 (de) | Hybridgel, das eine biologisch aktive Substanz sekretiert | |
| DE69233612T2 (de) | Verfahren zur bildung einer strukturellen und funktionellen diversität in einer peptidsequenz | |
| DE60131392T2 (de) | Verfahren zur schaffung von wirbeltier-spezifischer bauchspeicheldrüse in vitro | |
| EP1496112B1 (de) | Verfahren zur Isolierung von Inselzellen aus Pankreasgewebe | |
| DE60037876T2 (de) | Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes | |
| EP2209463A2 (de) | Kosmetisches verfahren zum erhöhen der pigmentierung von haut unter verwendung von melanozytenvorläuferzellen | |
| Griffin et al. | Comparison of harvesting methods for islet transplantation | |
| DE3781865T2 (de) | Klonierung von dns, welche einen menschlichen gip-vorlaeufer kodiert und expressionsverfahren des vorlaeufers. | |
| EP1419259A2 (de) | Verfahren zur reparatur einer mutierten rna aus einer gendefekten dna und zum gezielten abtöten von tumorzellen durch rna-transspleissen sowie verfahren zum nachweis von natürlich-transgespleisster zellulärer rna | |
| DE60131192T2 (de) | Aus nomuraea rileyi stammende ecdysteroid-22-oxidase und deren verwendung in einem system zur häutungshormon-inaktivierung | |
| DE60026334T2 (de) | Rekonstitution von nicht-menschlichen Säugerembryos durch nukleären Transfer | |
| DE10164805B4 (de) | Verfahren und Mittel zur Modifikation humaner Angiogenese | |
| DE60111818T2 (de) | Rekombinanter Vektor zur Gentherapie für Insulin-abhängige Diabetes mellitus und therapeutische Zusammensetzungen davon | |
| EP2603074B1 (de) | Verfahren zur herstellung desinfizierter humaner zellsuspensionen | |
| AT386608B (de) | Verfahren zum herstellen eines mikroorganismus | |
| WO2007143978A2 (de) | Verfahren zur induktion der insulinsynthese in chorionzellen | |
| Webb | Spermatogenesis in leeches I. Evidence for a gonadotropic peptide hormone produced by the supraoesophageal ganglion of Erpobdella octoculata | |
| DE19532906A1 (de) | Neue, definierte Enzymmischungen zur Zellgewinnung und für die Wundbehandlung | |
| DE4406072A1 (de) | Verfahren zur Herstellung von humanen, klonogenen Fibroblasten und so erhaltene Fibroblasten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8141 | Disposal/no request for examination |